EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
39 hedge funds and large institutions have $73.2M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
39
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.1M | |
| 2 | +$2.11M | |
| 3 | +$780K | |
| 4 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$779K |
| 5 |
SC
Sculptor Capital
New York
|
+$753K |
Top Sellers
| 1 | -$976K | |
| 2 | -$722K | |
| 3 | -$444K | |
| 4 |
Millennium Management
New York
|
-$308K |
| 5 |
DFCM
Dark Forest Capital Management
San Juan,
Puerto Rico
|
-$230K |